A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and With Autoimmune Disease)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This is a phase 1 study to evaluate the safety, tolerability, pharmacodynamics, and pharmacokinetics of VIS171 in healthy participants and in participants with autoimmune disease(s).
Epistemonikos ID: cf7f6cd4afd2393ed9f727c884e6f9af0aa1b269
First added on: Oct 02, 2023